Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Zogenix Inc. : Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results

05/03/2013 | 08:40am US/Eastern
Conference Call Scheduled for May 9, 2013 at 4:30 pm ET

SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results for the first quarter ended March 31, 2013, after the market closes on Thursday, May 9, 2013, and will hold a conference call on this day at 4:30 p.m. ET (1:30 p.m. PT), to discuss these financial results and provide a company update.

To access the live webcast please visit the Company's Investor Relations website at ir.zogenix.com, and to participate, please dial (866) 318-8616 (U.S.) or (617) 399-5135 (International); participant passcode: 65838569.

The conference call will be hosted by Chief Executive Officer Roger L. Hawley, President Stephen J. Farr, Ph.D., and Executive Vice President and Chief Financial Officer Ann Rhoads.

A replay of the conference call will be available beginning May 9, 2013 at 6:30 p.m. ET (3:30 p.m. PT) until May 16, 2013, by dialing (888) 286-8010 (U.S.) or (617) 801-6888 (International); passcode: 23471504. A replay of the webcast will also be accessible on the Investor Relations website for one month, through June 9, 2013.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX), with offices in San Diego and Emeryville, California, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Zogenix's first commercial product, SUMAVEL® DosePro® (sumatriptan injection) Needle-free Delivery System, was launched in January 2010 for the acute treatment of migraine and cluster headache. Zogenix's lead investigational product candidate, Zohydro™ ER (hydrocodone bitartrate), is an oral, extended-release formulation of various strengths of hydrocodone, without acetaminophen, intended for administration every 12 hours for around the clock management of moderate to severe chronic pain. In May 2012, Zogenix submitted to the FDA a New Drug Application for Zohydro ER. Zogenix's second investigational product candidate, Relday™, is a proprietary, long-acting injectable formulation of risperidone for the treatment of schizophrenia; an investigational new drug application was submitted to the FDA in May 2012. For additional information, please visit www.zogenix.com.

CONTACT: INVESTORS:
         Zack Kubow | The Ruth Group
         646.536.7020 | zkubow@theruthgroup.com

         MEDIA:
         Caitlin Cox | The Ruth Group
         646.536.7033 | ccox@theruthgroup.com
Zogenix
distributed by
React to this article
Latest news
Date Title
07:37a GOOGLE 'C' : Clinton's 'Homebrew' email server: Genius as well as sneaky?
07:36a MALAYSIA AIRPORTS BERHAD : ' senior management signs corporate integrity pledge
07:36a RESEARCH AND MARKETS : Global and Chinese Benzofluorfen Market Report 2014-2019
07:36aDJEU Scales Back Ukraine Sanctions
07:35a VERSO : reports 4Q loss
07:35a FURMANITE : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
07:34a AMINO TECHNOLOGIES : Re-shaping hospitality TV services for the “connected consumer” with OTT multiscreen
07:33aDJSAP SE : to Cut Jobs Amid Transition
07:32a FOOT LOCKER : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
07:31a Q TECHNOLOGY : Delta-Q Technologies to Introduce Electric Burden Carrier and Utility Vehicle Battery Chargers at ProMat 2015
Latest news
Advertisement
Hot News 
BELLZONE MINING : Financing Update and Restoration of Trading
SNOOZEBOX : Confirms Ealing Council Project With Mears Group
NORTHERN INVESTORS : 6 March 2015 - Tender Offer and Net Asset Value
THOMAS COOK : Cook and Fosun Strategic Partnership
MONCLER : boosted by growth from piste to the high street
Most Read News
03/05DJVOLKSWAGEN : to Announce Mexico Expansion Worth About $1 Billion -Reuters
03/05 WAREHOUSE : Summer shoppers go online with The Warehouse - growing sales 30%
03/05 BEACH ENERGY : Redemption of Convertible Notes
03/05DJE I DU PONT DE NEMOURS : DuPont : Plant Outage to Hurt Safety and Protection Unit in First Quarter
01:21a QUINDELL : in £7.1m sale of stake in accident repair firm Nationwide
Most recommended articles
07:36aDJEU Scales Back Ukraine Sanctions
07:33aDJSAP SE : to Cut Jobs Amid Transition
07:29aDJMore Bond Yields Edge to Negative Territory on ECB Comments -- 4th Update
07:26aDJMARKET SNAPSHOT : U.S. Stocks: Futures Waver Ahead Of Key Jobs Report
07:26aDJGERMANY : Greece Will Get Money Once Program Complete
Dynamic quotes  
ON
| OFF